Medications for Breast Cancer Earlyonset

1 result
  • kisqali - ribociclib tablet, film coated

    (Ribociclib)
    Novartis Pharmaceuticals Corporation
    Kisqali is used in adults with HR-positive, HER2-negative breast cancer. It treats high-risk stage II/III early breast cancer (with an aromatase inhibitor) and advanced or metastatic breast cancer (with an aromatase inhibitor or fulvestrant as initial or post-progression therapy).